Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Debruyne

Showing results (481-490 of 505) with videos related to

Pageof 51
Sort By:
Analytical and Quantitative Cytology and Histology|October 1, 1991
Morphometry, densitometry and pattern analysis of plastic-embedded histologic material from urothelial cell carcinoma of the bladderH G van der Poel, M E Boon, L P Kok, et al.
European Urology|January 1, 1990
A new longer-acting LHRH analog depot: preliminary results of a Dutch open phase II clinical study on a 10.8 mg Zoladex 3-monthly depotG A Dijkman, P Fernandez del Moral, J W Plasman, et al.
Urological Research|March 26, 1999
Transient tenascin enhancement is an early event after androgen ablation in rat prostateY Xue, J A van der Laak, M A Latijnhouwers, et al.
Urological Research|January 1, 1991
Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer. A flow cytofluorometric analysisE C de Boer, W H de Jong, A P van der Meijden, et al.
In Vivo (Athens, Greece)|November 1, 1987
Multiparameter analysis of four human renal cell carcinoma xenografts in nude miceH F Karthaus, W F Feitz, F C Ramaekers, et al.
The Journal of Urology|November 1, 1992
Impaired immune response by isoniazid treatment during intravesical BCG administration in the guinea pigL C De Boer, P A Steerenberg, P M Van der Meijden, et al.
Urological Research|January 1, 1993
The rat bladder tumor model system RBT resembles phenotypically and cytogenetically human superficial transitional cell carcinomaR J van Moorselaar, T Ichikawa, H E Schaafsma, et al.
The Journal of Urology|March 1, 1992
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancerD L Lamm, P M van der Meijden, A Morales, et al.
The Journal of Urology|January 1, 1993
Orchiectomy and nilutamide or placebo as treatment of metastatic prostatic cancer in a multinational double-blind randomized trialR A Janknegt, C C Abbou, R Bartoletti, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-GuérinE C De Boer, W H De Jong, A P Van Der Meijden, et al.
Pageof 51

Showing results (481-490 of 505) with videos related to

Sort By:
Pageof 51
Analytical and Quantitative Cytology and Histology|October 1, 1991
Morphometry, densitometry and pattern analysis of plastic-embedded histologic material from urothelial cell carcinoma of the bladderH G van der Poel, M E Boon, L P Kok, et al.
European Urology|January 1, 1990
A new longer-acting LHRH analog depot: preliminary results of a Dutch open phase II clinical study on a 10.8 mg Zoladex 3-monthly depotG A Dijkman, P Fernandez del Moral, J W Plasman, et al.
Urological Research|March 26, 1999
Transient tenascin enhancement is an early event after androgen ablation in rat prostateY Xue, J A van der Laak, M A Latijnhouwers, et al.
Urological Research|January 1, 1991
Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer. A flow cytofluorometric analysisE C de Boer, W H de Jong, A P van der Meijden, et al.
In Vivo (Athens, Greece)|November 1, 1987
Multiparameter analysis of four human renal cell carcinoma xenografts in nude miceH F Karthaus, W F Feitz, F C Ramaekers, et al.
The Journal of Urology|November 1, 1992
Impaired immune response by isoniazid treatment during intravesical BCG administration in the guinea pigL C De Boer, P A Steerenberg, P M Van der Meijden, et al.
Urological Research|January 1, 1993
The rat bladder tumor model system RBT resembles phenotypically and cytogenetically human superficial transitional cell carcinomaR J van Moorselaar, T Ichikawa, H E Schaafsma, et al.
The Journal of Urology|March 1, 1992
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancerD L Lamm, P M van der Meijden, A Morales, et al.
The Journal of Urology|January 1, 1993
Orchiectomy and nilutamide or placebo as treatment of metastatic prostatic cancer in a multinational double-blind randomized trialR A Janknegt, C C Abbou, R Bartoletti, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-GuérinE C De Boer, W H De Jong, A P Van Der Meijden, et al.
Pageof 51